Angelos Stergiou is President and Chief Executive Officer of SELLAS Life Sciences Group, Inc. (SLS). The company reported total compensation of $1,877,810 for fiscal year 2025.
| Salary | $676,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $477,107 |
| Option awards | $327,695 |
| Non-equity incentive plan | $390,390 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $6,618 |
| Total | $1,877,810 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure SELLAS Life Sciences Group, Inc. filed April 23, 2026, accession 0001104659-26-047693.
| Peer-group chief executive median | $3,723,563 |
|---|---|
| Difference from that median | $-1,845,752 |
| Percentile within the disclosed peer group | 1st |
| Peers with a disclosed figure | 2 |
Medians and percentiles are computed across the peer group SELLAS Life Sciences Group, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Angelos Stergiou this page | President and Chief Executive Officer | $1,877,810 |
| Dragan Cicic | Senior Vice President, Chief Development Officer | $991,795 |
| John Burns | Senior Vice President, Chief Financial Officer | $959,653 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full SELLAS Life Sciences Group, Inc. compensation brief.
Angelos Stergiou's compensation sits inside SELLAS Life Sciences Group, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The SELLAS Life Sciences Group, Inc. (SLS) compensation brief